Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ipragliflozin (ASP1941) is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $52 | In Stock | |
50 mg | $84 | In Stock | |
100 mg | $137 | In Stock | |
200 mg | $218 | In Stock | |
500 mg | $462 | In Stock | |
1 mL x 10 mM (in DMSO) | $48 | In Stock |
Description | Ipragliflozin (ASP1941) is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2. |
Targets&IC50 | SGLT2:5.64 nM, SGLT2 (human):7.4 nM, SGLT2 (rat):6.73 nM |
Kinase Assay | Inhibition of TNF-α synthesis: TNF-α inhibitory activity is measured in lipopolysacharide (LPS) stimulated PBMC. Pomalidomide is added to human PBMCs 1 hour prior to the addition of LPS (1 μg/mL) and incubation continued for an additional 18-20 hours. Supernatants are then harvested, and the concentration of TNF-α in the supernatants is determined by ELISA. The concentration of Pomalidomide that inhibits TNF- production by 50% (IC50) is calculated by nonlinear regression analysis. The human whole blood TNF- inhibition assay is run in a similar fashion to the PBMC assay except that heparinized fresh human whole blood is plated directly into microtiter plates. |
Alias | ASP1941 |
Molecular Weight | 404.45 |
Formula | C21H21FO5S |
Cas No. | 761423-87-4 |
Smiles | O[C@H]1[C@@H](O[C@H](CO)[C@@H](O)[C@@H]1O)C2=CC(CC3=CC=4C(S3)=CC=CC4)=C(F)C=C2 |
Relative Density. | 1.452 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 70 mg/mL (173.07 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.